Life Stem Genetics, Inc. engages in the operation of stem cell therapy-based clinics. The company is headquartered in Beverly Hills, California and currently employs 1 full-time employees. The company went IPO on 2013-04-11. The firm is exploring to engage in cell therapy research and life science in general.
Life Stem Genetics Inc 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
Life Stem Genetics Inc 的收入按细分市场或地理位置如何划分?
Life Stem Genetics Inc 最大收入来源是 Drinkable Kefir Other than ProBugs,在最近的收益报告中收入为 153,493,000。就地区而言, United States 是 Life Stem Genetics Inc 的主要市场,收入为 186,820,000。